New plans for faster, better and more convenient care for the millions of people who suffer from bone and joint ailments such as arthritis, back pain and fractures were announced today by Health Minister Andy Burnham.
The Department of Health today announced a package of measures to improve safety on inpatient mental health settings, including targeting ?30 million capital funding to improve the sexual safety of female patients.
A public interest litigation has been filed in Kolkata, demanding that the West Bengal government foot the bill for the medical treatment of any one who has contracted HIV, Hepatitis B or C in the last one year. This is because those suffering may have contracted the disease because the state health department was using faulty diagnostic kits.
Merck & Co., Inc. announced that the U.S. Centers for Disease Control and Prevention (CDC) has added Merck’s cervical cancer vaccine, GARDASIL? [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the CDC’s Vaccines for Children (VFC) contract for girls and women aged 9 to 18. GARDASIL was approved on June 8 by the Food and Drug Administration (FDA) for use in girls and women ages 9 to 26 years. GARDASIL is the world’s first and only vaccine available for the prevention of HPV types 16- and 18-related cervical cancer, cervical pre-cancers (CIN 2/3 and AIS), vulvar pre-cancers (VIN 2/3) and vaginal pre-cancers (VaIN 2/3) and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by HPV types 6, 11, 16 and 18.
Earlier studies suggest that children with type 1 diabetes are more likely to have a subsequent diagnosis of celiac disease. However, research is sparse on the risk of subsequent type 1 diabetes in individuals with celiac disease. We sought to determine the risk of subsequent type 1 diabetes diagnosed before the age of 20 years in children and adolescents with celiac disease in a national, general population-based cohort – Jonas F. Ludvigsson, Department of Pediatrics, ?rebro University Hospital, ?rebro.
Huge amounts of money – up to $50 billion – are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.
Pharmion Corporation (Nasdaq: PHRM) announced today the enrollment of the first patient in AVIDA(TM), a registry for patients treated with Vidaza(R) (azacitidine for injectable suspension). Vidaza was approved in May 2004 for the treatment of all five French-American-British (FAB) subtypes of myelodysplastic syndromes (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Myelodysplastic syndromes are a serious and life-threatening group of diseases in which the bone marrow does not function normally, resulting in the production of malformed or immature blood cells.
The odds of a woman in Pakistan being blind are 30 percent higher than for a Pakistani man according to a new survey published in the November 2006 issue of Investigative Ophthalmology & Visual Science (IOVS).
Breakthroughs in Sensitivity and Resolution Benefit Patients, Fundamentally Change How Doctors Will Diagnose and Treat Cancer and Heart, Brain Diseases, Notes Article in November Journal of Nuclear Medicine – Imagine a new world of detecting and diagnosing diseases sooner?even before any symptoms are present. Consider the possibility of receiving individualized, targeted molecular, cellular or genetic medical treatment as soon as possible and of undergoing scanning that can quickly tell your doctor whether your treatment is working. Continued advances in positron emission tomography (PET) imaging are key to this future, according to Simon R. Cherry, professor of biomedical engineering at the University of California, Davis.
Seeing the funny side of things and realising that other people are worse off than them are the two top coping strategies used by people caring for someone over 75, according to research in November issue of Journal of Clinical Nursing.